No 1 Date of announcement 2025/11/25 Time of announcement 16:45:40 Subject Oneness Biotech Co., Ltd. receives a Korean patent titled “TREATING IGE-MEDIATED ALLERGIC DISEASES” on FB825. To which item it meets Subparagraph 53 Date of events  2025/11/25 Statement Date of occurrence of the event: 2025/11/25 Company name: ONENESS BIOTECH CO., LTD Relationship to the...Read More

  No 1 Date of announcement 2025/11/12 Time of announcement 16:54:15 Subject Oneness Biotech Co., Ltd. receives a Canadian patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets Subparagraph 53 Date of events  2025/11/12 Statement Date of occurrence of the event：2025/11/12 Company name: ONENESS BIOTECH...Read More

  No 1 Date of announcement 2025/11/10 Time of announcement 16:44:25 Subject The Company’s 2025Q3 consolidated financial statements have been approved by the Board of Directors. To which item it meets Subparagraph 10 Date of events  2025/11/10 Statement Date of the board of directors submitted or approved:2025/11/10 Date of the audit committee approved:2025/11/10 Start and...Read More